Montmorillonite

Generic Name: Montmorillonite

Drug Type: Small Molecule

Chemical Formula: Al_₂H_₂O_₁₂Si_₄

CAS Number: 1318-93-0

Unique Ingredient Identifier: A585MN1H2L

Overview

No overview information available.

Indication

No indication information available.

Associated Conditions

Acute Diarrhea
Chronic Functional Diarrhea

Clinical Trials

Title	Posted	Study ID	Phase	Status	Sponsor
A Comprehensive Analysis of the Comparative Efficacy of Multimodal Diarrhea Therapies in the Paediatric Population	2024/09/09	NCT06588036	Early Phase 1	Not yet recruiting	Combined Military Hospital Multan
Effect of Montmorillonite Power or Loperamide on the Pharmacokinetics of Pyrotinib in Healthy Subjects	2022/02/23	NCT05252546	Phase 1	Completed	Jiangsu HengRui Medicine Co., Ltd.
Evaluation of Smectite Effect As A Food Thickener On Gastroesophageal Reflux Disease In Neonates Using Combined Esophageal Multichannel Intraluminal Impedance	2021/03/09	NCT04788485	Phase 4	Completed	Ain Shams Maternity Hospital
The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19	2020/07/21	NCT04479202	Phase 4	Completed	Chinese Medical Association
Chronic Administration of Diosmectite (SMECTA®) in Subjects With Chronic Diarrhoea	2017/02/08	NCT03045926	Phase 1	Completed	Ipsen
Efficacy of Diosmectite (Smecta®) in the Symptomatic Treatment of Acute Diarrhoea in Adults	2016/03/09	NCT02704091	Phase 4	Completed	Ipsen
Evaluation of the Efficacy of Low-dose Acetylsalicylic Acid on Diarrhea Induced by Anti-cancer Targeted Therapies.	2014/12/23	NCT02323516	Phase 2	Withdrawn	Centre Francois Baclesse
Study to Evaluate Smecta® vs Placebo on the Time to Recovery Following an Acute Diarrhoea Episode in Adults	2006/01/13	NCT00276328	Phase 4	Completed	Ipsen

FDA Drug Approvals

Approved Product	Manufacturer	NDC Code	Route	Strength	Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product	Authorization Holder	Status	Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product	Manufacturer	Approval Number	Dosage Form	Strength	Approval Date
SMECTA SACHET 3 g/sachet	BEAUFOUR IPSEN INDUSTRIE	SIN06338P	POWDER	3g/sachet	7/3/1991

NMPA Drug Approvals

Approved Product	Company	Approval Number	Drug Type	Dosage Form	Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product	Registration No.	Company	Licence No.	Strength	Registration Date
SMECTA STRAWBERRY POWDER FOR ORAL SUSPENSION 3G	N/A	DCH Auriga (Hong Kong) Limited	N/A	N/A	5/24/2022

TGA Drug Approvals

Approved Product	ARTG ID	Sponsor	Registration Type	Status	Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product	Company	DIN	Dosage Form	Strength	Market Date
No Health Canada approvals found for this drug.

CIMA AEMPS Drug Approvals

Approved Product	Company	Registration Number	Pharmaceutical Form	Prescription Type	Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product	Company	Registration Number	Dosage Form	Strength	Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name	MA Holder	MA Number	Pharmaceutical Form	Active Ingredient	Authorization Date
No UK EMC drug information found for this drug.

Related News

No news found

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.